XML 146 R117.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Collaborative and Other Relationships (Details 3) (AbbVie, USD $) In Millions, unless otherwise specified | 12 Months Ended
--- | ---
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011
AbbVie |  |  |
Summary of activity related to collaboration with Facet Biotech |  |  |
Total expense incurred by collaboration | $ 133.4 | $ 128.0 | $ 105.2
Biogen Idec's share of expense reflected within our consolidation statements of income | $ 71.0 | $ 65.6 | $ 54.2

X
- Definition Total expense incurred by collaboration. + References No definition available. + Details
Name: | biib_ExpenseIncurredByCollaboration
Namespace Prefix: | biib_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Biogen Idec's share of expense reflected within our consolidated statements of income. + References No definition available. + Details
Name: | biib_ExpenseReflectedWithinStatementsOfIncome
Namespace Prefix: | biib_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | biib_SummaryOfActivityRelatedToCollaborationWithCompanySevenAbstract
Namespace Prefix: | biib_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration